-
Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer
10 Feb 2022 12:30 GMT
… W. Frohlich, M.D., Chief Executive Officer, Indapta Therapeutics (Photo: Business … executive vice president at Dendreon Corporation, a pioneer … of cellular immunotherapy. At Dendreon, he led the … strategy officer.”
Before joining Dendreon, Dr. Frohlich served …
-
GRAIL Announces Appointment of Hans Bishop as Chief Executive Officer and Strengthens Leadership Team and Board of Directors with New Appointments
06 Jun 2019 21:01 GMT
… Bishop has been appointed as Chief Executive Officer, effective immediately. He succeeds … Hans is stepping into the CEO role to continue building … excited to step into the CEO role at a time … and Chief Operating Officer for Dendreon, Inc. He also previously …
-
John H. Johnson Agrees to Become Permanent Chief Executive Officer of Melinta Therapeutics
19 Dec 2018 13:31 GMT
… agreed to become the permanent chief executive officer (CEO) of Melinta, subject to … served as president and chief executive officer of Dendreon Corporation from February 2012 … June 2014 and president and chief executive officer until August 2014. Prior …
-
Melinta Therapeutics Announces Appointment of John H. Johnson as Interim Chief Executive Officer
22 Oct 2018 12:00 GMT
… John H. Johnson as interim chief executive officer (CEO), effective immediately. Mr. Johnson … H. Johnson, interim chief executive officer and director of Melinta Therapeutics … as president and chief executive officer of Dendreon Corporation from February …
-
Bluejay Therapeutics Announces Expansion of Leadership Team and Board of Directors
21 Nov 2024 14:00 GMT
… D., Ph.D., Founder and Chief Executive Officer of Bluejay Therapeutics. “We … Nuvelo, Novacept, IntraBiotics Pharmaceuticals and Dendreon. García currently serves on the … is the former President and Chief Executive Officer of Chinook Therapeutics and …
-
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
13 Nov 2024 13:00 GMT
… Julie Eastland has been appointed Chief Executive Officer, President and Director, succeeding … ,” said Julie Eastland, incoming Chief Executive Officer of Zentalis. “The azenosertib … publicly traded biotechnology companies including Dendreon and Amgen. Ms. …
-
Dendreon Pharmaceuticals Appoints Sherry Saurini as Vice President of Quality
23 Aug 2021 13:00 GMT
… , Calif.--(BUSINESS WIRE)--Dendreon Pharmaceuticals, a commercial-stage biopharmaceutical … programs.” said Jason O’Neill, CEO of Dendreon Pharmaceuticals. "Sherry’s … future of cell therapy.”
About Dendreon
Dendreon is a commercial-stage biopharmaceutical …
-
OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx
22 Jun 2021 15:10 GMT
… Katherine Stueland as President and Chief Executive Officer of GeneDx, Inc., the global … Ms. Stueland, incoming President and CEO of GeneDx. "I… . Stueland previously held roles at Dendreon Corporation and TAP Pharmaceuticals (a …
-
Targazyme Appoints Jim Caggiano as CEO
11 Sep 2020 14:21 GMT
… Caggiano to be the CEO, focused initially on its … Abbott Laboratories, Valeant, and Dendreon. As President at Valeant, … turnaround of Dendreon, doubled the value of Dendreon by selling … and became its CEO. Under his leadership, Dendreon earned over $100M …
About
© 1995-2025